id: medication_access_to_aud_remission
name: Medication Access â†’ Alcohol Use Disorder Remission
from_node:
  node_id: medication_access
  node_name: Medication Access
to_node:
  node_id: aud_remission
  node_name: Alcohol Use Disorder Remission
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Access to medications (likely pharmacotherapy for AUD such as naltrexone,
  acamprosate, or disulfiram) reduces physiological cravings and withdrawal symptoms'
- 'Step 2: Medications modify neurobiological reward pathways and reduce reinforcing
  effects of alcohol consumption'
- 'Step 3: Medication access requires healthcare system engagement, creating structured
  treatment relationships and monitoring'
- 'Step 4: Pharmacological treatment support enables individuals to engage more effectively
  in behavioral and social recovery interventions'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'S. Kinreich et al. 2021. "Predicting alcohol use disorder remission:
    a longitudinal multimodal multi-featured machine learning approach." *Translational
    Psychiatry*. https://doi.org/10.1038/s41398-021-01281-2'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.851665'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: sex
  direction: strengthens
  strength: moderate
  description: Medication was identified as discriminative feature in sex-stratified
    prediction models
- name: ancestry
  direction: strengthens
  strength: moderate
  description: Medication use contributed to prediction accuracy particularly in African
    ancestry male models
